478832-60-9 Usage
General Description
6-Methyl-1H-indazol-5-ol is a chemical compound that falls under the category of indazoles, which are organic compounds containing a benzene ring fused to a pyrazole ring. The specific formula for this chemical is C9H9N3O, suggesting it contains nine atoms of carbon, nine of hydrogen, three of nitrogen, and one of oxygen. It's a somewhat complex compound that finds utility in various fields, primarily in the medicinal chemistry and drug discovery due to the biological activity of indazole derivatives. Specific data about its toxicity, ecological information, and detailed experimental properties might be relatively scarcely available in the public domain. So, potential users must handle it with care and take standard precautionary measures while dealing with such chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 478832-60-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,8,8,3 and 2 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 478832-60:
(8*4)+(7*7)+(6*8)+(5*8)+(4*3)+(3*2)+(2*6)+(1*0)=199
199 % 10 = 9
So 478832-60-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H8N2O/c1-5-2-7-6(3-8(5)11)4-9-10-7/h2-4,11H,1H3,(H,9,10)
478832-60-9Relevant articles and documents
MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF
-
Page/Page column 112, (2008/12/05)
Novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, and/or AP-1, and/or NF-κB activity including inflammatory and immune diseases, obesity and diabetes having the structure of formula (I), its enantiomers, diastereomers, or a pharmaceutically-acceptable salt, or hydrate, thereof, wherein (Ia) is heterocycle or heteroaryl; J, Ja, E, F, G, Ma, M, Q, Za and Z are as defined herein. Also provided are pharmaceutical compositions and methods of treating inflammatory- or immune-associated diseases and obesity and diabetes employing said compounds.
